银杏达莫注射液对急性冠脉综合征患者脂代谢、血小板聚集性的影响被引量：2

Effect of Ginkgo Dipyidamolum Injection on Lipid Metabolism and Platelet Aggregation in Patients with Acute Coronary Syndrome

暂未订购

导出

摘要目的分析急性冠脉综合征(ACS)经银杏达莫注射液治疗的效果,并探讨该药物对病患血小板聚集、脂代谢的影响。方法选择我院收治的90例急性冠脉综合征病患进行研究,随机分为A、B组各45例。A组给予常规西药治疗,B组在此基础上加用银杏达莫注射液治疗,比较两组心绞痛疗效、血小板聚集率、血脂水平、不良反应。结果 (1)心绞痛改善有效率:B组为95.56%,A组为80.00%,B组有效率比A组更高,具有差异性(P<0.05);(2)B组治疗后的血脂水平明显改善,与A组(均低于A组)比较有统计学意义(P<0.05);(3)B组经治疗后,血小板聚集率下降,低于A组,组别间比较有差异(P<0.05);(4)不良反应率:B组(4.44%)与A组(2.22%)相比无差异性(P>0.05)。结论 ACS患者采用银杏达莫注射液治疗,能缓解心绞痛症状,改善血小板聚集率以及脂代谢,值得临床推广。 Objective To analyze the effect of ginkgo dipyidamolum injection in the treatment of acute coronary syndrome （ACS）, and explore its influence on lipid metabolism and platelet aggregation. Methods A total of 90 patients with acute coronary syndrome in our hospital were were taken as the clinical research objects, and they were randomly divided into A group （45 cases） and B group （45 cases）. Both groups were treated with conventional western medicine, besides, the B group was given additional ginkgo dipyidamolum injection. The improvement of angina pectoris, platelet aggregation rates, lipid levels and adverse reactions in the two groups were compared. Results The effective rate of angina pectoris improvement in the B group was 95.56% which was higher than that in the A group 80.00%, and their difference was statistically significant（P〈0.05）. After treatment,the lipid level in the B group was obviously improved, and it was significantly lower than that in the A group（P〈0.05）, the platelet aggregation rate in the B group was decreased, and it was significantly lower than that in the A group （P〈0.05）. The adverse reaction rates in the B and A group were respectively 4.44% and 2.22%, the difference between the two groups was not statistically significant（P〉0.05）. Conclusion Ginkgo dipyidamolum injection can not only relieve angina symptoms in ACS patients, but also improve platelet aggregation rate and lipid metabolism. Thus, it is worthy of application in clinic.

作者赵志强郭敬玲 ZHAO Zhi-qiang GUO Jing-ling.(Department of Medicine, Huixian Public Hospital, Huixian 453600, Henan Province, Chin)

机构地区河南省辉县市公费医疗医院内一科

出处《罕少疾病杂志》 2017年第4期15-16,24,共3页 Journal of Rare and Uncommon Diseases

关键词血小板聚集脂代谢 ACS 银杏达莫 Platelet Aggregation Lipid Metabolism ACS Ginkgo Dipyidamolum

分类号 R331.143 [医药卫生—人体生理学]

引文网络
相关文献

参考文献5

1张奇,沈卫峰.非ST段抬高型急性冠脉综合征治疗策略流程——2014AHA/ACC指南解读[J].国际心血管病杂志,2015,42(2):65-67. 被引量：31
2葛海龙,史冬梅,王建龙,韩洪亚,刘晓丽,马茜,周玉杰.急性冠脉综合征患者介入术后慢血流事件与血浆D-二聚体水平关系[J].中华急诊医学杂志,2016,25(4):475-478.
3李玲,罗晓丽,王红勇.三种肝素类药物在急性冠脉综合征治疗中的应用效果分析[J].标记免疫分析与临床,2015,22(7):611-613. 被引量：5
4李晶晶,陈逸伦,马永东,高洁,耿晓雯,任艺虹.替格瑞洛与氯吡格雷对急性冠脉综合征患者经皮冠脉动脉介入术后血小板抑制效果的比较[J].现代生物医学进展,2015,15(18):3462-3465. 被引量：30
5魏国敲.银杏达莫注射液治疗急性冠脉综合征合并高脂血症的临床观察[J].中国中西医结合急救杂志,2016,23(4):386-389. 被引量：4

二级参考文献68

1韦兵,王元星,贺大璞.吉非罗齐对高脂血症兔心肌缺血再灌注损伤的影响及机制[J].中国动脉硬化杂志,2008,16(12):938-942. 被引量：4
2蒋军广,谭伟丽,王丽华,王毅,田蕊,帖永新.银杏叶提取物对老年肺心病患者抗脂质过氧化损伤的影响[J].中国危重病急救医学,2006,18(4):246-247. 被引量：28
3Amsterdam EA, Wenger NK, Brindis RG, et al. 2014 AHA/ ACC guideline for the management of patients with non-ST- elevation acute coronary syndromes., executive summary: a report of the american college of cardiology/american heart association task force on practice guidelines[J]. J Am Coll Cardiol,2014,64(24) : e139-e228.
4Cannon CP, Weintraub WS, Demopoulos LA, et al. Comparison of early invasive and conservative strategies in patients with unstable coronary syndromes treated with the glycoprotein II b/Ill a inhibitor tirofiban[J]. N Engl J Med, 2001,344~ 1879-1887.
5de Winter RJ, Windhausen F, Cornel JH, et al. Early invasive versus selectively invasive management for acute coronary syndromes[J]. N Engl J Med,2005,353(11)..1095-1104.
6Fox KA, Poole-Wilson PA, Henderson RA, et al. Interventional versus conservative treatment for patients with unstable angina or non-ST-elevation myocardial infarction: the British Heart Foundation RITA 3 randomised trial. Randomized Intervention Trial of unstable Angina[J]. Lancet, 2002,360 (9335) : 743-751.
7Mehta SIR, Cannon CP, Fox KA, et al. Routine vs selective invasive strategies in patients with acute coronary syndromes: a collaborative meta-analysis of randomized trials[J]. JAMA, 2005,293(23) ~ 2908-2917.
8Fox KA, Clayton TC, Damman P,et al. Long-term outcome of a routine versus selective invasive strategy in patients with non-ST-segment elevation acute coronary syndrome a meta- analysis of individual patient data[J]. J Am Coll Cardiol, 2010,55 (22) : 2435-2445.
9Fox KA, Poole-Wilson P, Clayton TC, et al. 5-year outcome of an interventional strategy in non-ST-elevation acute coronary syndrome: the British Heart Foundation RITA 3 randomised trial[J]. Lancet, 2005,366 (9489) : 914-920.
10Damman P, Hirsch A, Windhausen F, et al. 5-year clinical outcomes in the ICTUS (Invasive versus Conservative Treatment in Unstable coronary Syndromes ) trial a randomized comparison of an early invasive versus selective invasive management in patients with nowST-segment elevation acute coronary syndrome[J]. J Am Coll Cardiol, 2010,55 (9) .. 858-864.